Medgate does 10,000 consultations daily in Switzerland and an estimation of 5,000 in the Philippines. Alodokter does 15,000 consultations daily.
Lets say 20% are respiratory, so 2,000 Medgate consults at $5 = $10,000 which equates to $3,650,000 yearly. Philippines 1,000 at $1 = $365,000 yearly.
Alodokter 3,000 daily consults at $1 = $3,000 which equates to $1,095,000 yearly.
So a total of $5,110,000 just from these three alone. Where will this number be if/when we sign 2, 5,10 other providers. What about signing with the UK's NHS? Or Ping An?
Do we dare to dream? Lets say the COVID cough gets approved. At 10c a cough and 10,000,000 coughs are used (wildly under valuing numbers) means $1,000,000 daily and $365,000,000 yearly revenue.
Most probably the COVID cough revenue will be by licence but on my numbers it could be close. The volume could be 10 times this. Others, please tell me I'm dreaming if you disagree.
So, this company could go to stratospheric if just a few things fall into our laps.
I know this is dangerous talk because it is just speculation, but, hey, the SP is going in the right direction so others are seeing something good here.
I am not a mathematician so my numbers may be wonky, but from where I am sitting I like what I see.
RAP Price at posting:
7.2¢ Sentiment: Buy Disclosure: Held
